Framing it as picking up a company at PE 3 is fair enough. Though new overheads and whats not may stretch that generous PE rating. Just hoping for the share price to drift north now. The L7 bump was nearly two years back now!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential